Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward Commercialization CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has signed a new 10-year commercial manufacturing and supply agreement with a key existing customer. This represents the latest agreem...
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale Fortifies Balance Sheet and Reinforces Disciplined Capital Management Approach CHASKA, Minn., June 12, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has received the remaining $10 million in proceeds from the previously disclosed sale of its excess high-speed, multi-purpose 10-head isolator filler. The buyer elected to complete the full paymen...
Moody's Ratings (Moody's) has assigned Affiliated Managers Group, Inc.'s (AMG) senior unsecured shelf rating at (P)A3, and junior subordinate shelf rating at (P)Baa1. The outlook remains stable. RATINGS RATIONALE The ratings reflect the company's solid operating performance driven by assets unde...
AMG Names Thomas M. Wojcik as President and Chief Operating Officer WEST PALM BEACH, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced the appointment of Thomas M. Wojcik as President, effective June 3, 2025. Mr. Wojcik will also continue to serve as Chief Operating Officer. Jay C. Horgen, previously President and Chief Executive Officer, will continue as Chief Executive Officer. In his expanded role, Mr. Wojcik will continue to work with Mr. Horgen on developing and executing AMG’s growth strategy...
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations Will Leverage Deep Pharma Services Expertise as Leader of Lifecore’s Sales Organization Focused on Executing Three-Pronged Growth Strategy CHASKA, Minn., May 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has appointed Mark DaFonsec...
Crown Castle Declares Quarterly Common Stock Dividend HOUSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today that its Board of Directors has declared a quarterly cash dividend of $1.0625 per common share. The quarterly dividend will be payable on June 30, 2025 to common stockholders of record at the close of business on June 13, 2025. Future dividends are subject to the approval of Crown Castle's Board of Directors. ABOUT CROWN CASTLE Crown Castle owns, operates and leases more than 40,000 cell towers and approximately 90,000 route miles...
Crown Castle to Present at Nareit’s REITweek: 2025 Investor Conference HOUSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today that Dan Schlanger, Crown Castle’s Interim President and Chief Executive Officer, and Sunit Patel, Crown Castle’s Executive Vice President and Chief Financial Officer, are scheduled to present on Wednesday, June 4, 2025 at 2:45 p.m. Eastern Time at Nareit’s REITweek: 2025 Investor Conference. The presentation will be broadcast live over the Internet and is expected to last approximately 30 minutes. The live audio we...
AMG Reports Financial and Operating Results for the First Quarter of 2025 Company reports EPS of $2.20, Economic EPS of $5.20 in the first quarter New partnerships with and Qualitas Energy, together with Q1 investment in , further diversify AMG’s business and broaden its participation in alternatives, in line with its growth strategyAffiliate to be acquired, marking culmination of AMG investment and a successful outcome for all stakeholdersStrong net client cash inflows in alternatives of approximately $14 billion, driven by both liquid alternatives and private marketsRepurchased approx...
AMG and Qualitas Energy Announce Partnership AMG to invest in Qualitas Energy, a leading renewables-focused global infrastructure manager specializing in energy transition with more than €3.5 billion in AUMQualitas Energy has a distinctive competitive position given its opportunistic value-add approach, vertically integrated industrial platform, and strategically tailored, market-specific solutionsPartnership will expand AMG’s participation in private markets and alternatives more broadly WEST PALM BEACH, FL, and MADRID, May 08, 2025 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leadin...
Four Directors at Crown Castle Inc sold 34,410 shares at between 106.370USD and 106.900USD. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Peppertree Capital Management to Be Acquired by TPG Marks Successful Culmination of AMG Partnership WEST PALM BEACH, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced that it has entered into an agreement to sell its equity interest in Peppertree Capital Management, Inc. (“Peppertree”) as part of the announced acquisition of Peppertree by TPG Inc. Founded in 2004 by co-Presidents Ryan Lepene and Howard Mandel, Peppertree is a leading specialized digital infrastructure investment firm with a focus ...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
This note covers changes to the model and establishes a starting valuation for the Company of $125 (+18%; total return of +22%). We are above the mid-point of guidance for 2025 and for AFFO post close. We expect Consensus estimates for both to increase (post close estimates should increase a lot). See our prior note on results and the rationale for our upgrade to Buy.
AMG to Announce First Quarter Results on May 8, 2025 Conference Call Scheduled for 12:00 p.m. Eastern Time WEST PALM BEACH, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- AMG (NYSE: AMG) will report financial and operating results for the first quarter ended March 31, 2025 before the market opens on Thursday, May 8, 2025. A conference call will be held at 12:00 p.m. Eastern time on the same day. In addition to quarterly results, the conference call may include discussion of management’s expectations of future financial and operating results. Jay C. Horgen, President and Chief Executive Officer...
Revenues beat estimates on better organic leasing and better services. Cash EBITDA beat handily, mostly on lower SG&A. AFFO beat handily too. Management didn’t change guidance. We think they are forecasting conservatively. We expect Consensus estimates to rise, landing above the mid-point of the current guidance range
Crown Castle Reports First Quarter 2025 Results and Maintains Outlook for Full Year 2025 HOUSTON, April 30, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") today reported results for the first quarter ended March 31, 2025 and maintains its full year 2025 Outlook, as reflected in the table below. (dollars in millions, except per share amounts)Current Full Year 2025 Outlook Midpoint(a) Full Year 2024 Actual Change % ChangeSite rental revenues(b)$4,010 $4,268 $(258) (6)%Net income (loss)$205 $(3,903) $4,108 N/ANet income (loss) per share—diluted$0.47 $(8.98) $9.45 N/A...
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO Live 2025 conference. Billed as a premiere partnering event for the biopharma outsourcing industry, CDMO Live will take place May 7-8, 2025, in Rotterdam, Netherlands. During the conference, Jackie Klecker, Lifecore’s executive vice president, quality and development ...
AMG Announces Investment in Verition Fund Management AMG to acquire a minority equity interest in Verition, a global multi-strategy investment firm with $12.6 billion in AUMVerition’s management will retain a substantial majority of the firm’s equity and continue to lead Verition as an independent firm, in line with AMG’s partnership approachPartnership further diversifies AMG’s business and increases its exposure to alternative strategies WEST PALM BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today ...
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore granted a restricted stock unit (“RSU”) award with respect to 45,000 shares of its common stock, an option for 210,000 shares of stock, an RSU for 170,000 shares of common stock, and a performance stock unit (“PSU”) award for up to 370,000 shares of its common stock to Thomas D. Salus, Lifecore’s newly hi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.